BioPharma
11 October, 2024 | Friday | News
Astellas Secures Exclusive Option for AVB-101 Gene Therapy in $2.18 Billion Deal with AviadoBio
Astellas receives an exclusive option to license AVB-101, an investigational, AAV-based gene therapy in Phase 1/2 development AviadoBio receives $20 million equity investmen...
Lab
14 October, 2024 | Monday | News
Thermo Fisher Introduces Iliad (S)TEM: Advancing Atomic-Level Insights with EELS and NanoPulser Technology
Thermo Scientific Iliad integrates electron energy loss spectroscopy (EELS) and NanoPulser electrostatic beam blanker to improve insights at the atomic level Thermo Fisher Scientific Inc., the world leader in ...
BioTech
14 October, 2024 | Monday | News
Waters Corporation Launches Advanced LC-MS Tools to Accelerate RNA Therapeutic Development
Waters Corporation unveiled a new suite of liquid chromatography-mass spectrometry (LC-MS) grade reagents, enzymes, and software designed to simplify the analysis of large molecule RNA therapeutics. The compreh...
Contract Services
11 October, 2024 | Friday | News
Leading Drug Discovery CRO NovAliX Partners with Bruker to Transform Therapeutic Innovation
Bruker Acquires Minority Stake in NovAliX in Strategic Move Partnership Leverages Synergies Between Premium Drug Discovery CRO and High-Value Life Science Instrument Maker Focus on Enhancing Drug Discovery ...
Consumer Health
11 October, 2024 | Friday | News
CanSinoBIO Secures Over $17 Million Grant to Propel Polio Vaccine Trials in Indonesia and Advance Global Eradication Efforts
CanSino Biologics has announced a milestone in its fight against polio. The company has received an additional financial boost, securing a grant exceeding US$17 million to propel its recombinant poliovirus vacc...
White Paper
30 August, 2024 | Friday | Report
New Trials, New Pills—The Pharma Rollercoaster Continues!
Product Spot Light
14 October, 2024 | Monday | News
Waters Corporation Launches Advanced LC-MS Tools to Accelerate RNA Therapeutic Development
Premium Article
20 September, 2024 | Friday | Opinion
The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
Bio Invest
10 October, 2024 | Thursday | News
ShiraTronics Raises $66M in Series B to Advance Innovative Neuromodulation Therapy for Chronic Migraine Patients
Biopharma APAC Infomercial
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
